News
May 30, 2007 -- As concern and investigation continue concerning the link between drug-eluting stents and late-stent ...
May 29, 2007
News
May 30, 2007 -- Daxor Corp., a medical instrumentation and biotechnology company, announced the June 2007 publication of ...
May 29, 2007News
May 30, 2007 -- Xtalks and eResearchTechnology will present a Web conference titled, "Best Practices in Cardiac Safety Data Collection Before and After the Thorough QT Trial," on June 7, 10 a.m. to noon, EDT.
May 29, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
May 30, 2007 -- The Canadian Press reports this week that people in the greatest need of cardiac medications and interventions are less likely than moderately ill patients to get the full range of heart drugs and procedures, and it may be because they fail the "eyeball" test.
May 29, 2007News
May 30, 2007 — Cardiovascular Associates, Kingsport, TN, has announced the successful implant of a new investigational ...
May 29, 2007News
May 29, 2007 — Frost & Sullivan is launching a new end user study on the state of adoption for atrial fibrillation ...
May 28, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
May 29, 2007 — Stentys says the results of preclinical testing of its bifurcated stent were reported at last week's ...
May 28, 2007News
May 29, 2007 — The Centers for Medicare & Medicaid Services (CMS) announced on May 25 a decision to provide coverage for Doppler monitoring of cardiac output in certain settings, removing the past noncoverage of this diagnostic test in these settings and adopting an evidence-based approach to healthcare.
May 28, 2007News
May 29, 2007 — Medtronic Inc. has enrolled the first patient in the landmark PROTECT clinical study, the largest ...
May 27, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
May 29, 2007 — The FDA has cleared the CORDIS ENTERPRISE Vascular Reconstruction Device and Delivery System under the Humanitarian Device Exemption — it is used with embolic coils for the treatment of intracranial aneurysms. It consists of a self-expanding stent and a delivery system. The stent serves as a scaffold for embolic coils to prevent herniation of the coils into the parent vessel.
May 27, 2007News
May 29, 2007 — Abbott announced positive results last week from ABSORB, the world’s first clinical trial evaluating the ...
May 27, 2007News
May 29, 2007 — Doctors at University of Pittsburgh Medical School, (UPMC) have begun a study using an investigational ...
May 27, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
May 29, 2007 — Abbott announced Friday, May 25, that it has initiated a voluntary, nationwide recall of its ARCHITECT ...
May 27, 2007News
May 29, 2007 — Boston Scientific Corp. has received CE Mark for its TAXUS Liberte Long paclitaxel-eluting coronary stent ...
May 27, 2007News
May 29, 2007 — The FDA has cleared the Mynx VCS vascular closure system (VCD) by AccessClosure designed to seal a ...
May 27, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now